NANO MRNA CO.,LTD. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 181 JPY | +2.84% |
|
+1.12% | -4.74% |
| 2023 | NANO MRNA, Kao Tie Up to Develop mRNA Therapies for Allergic Diseases | MT |
| 2023 | NANO MRNA Co., Ltd. and Kao Corporation Agree a Comprehensive Collaborative Research for mRNA Drug Discovery | CI |
Nano Mrna Co Ltd, formerly NanoCarrier Co Ltd, is mainly engaged in the research and development, manufacturing and sales of pharmaceuticals. The Company develops businesses using the research and development of messenger ribonucleic acid (mRNA) medicine. The products under development are specialized in mRNA medicines. mRNA medicine is a medicine that prevents or treats diseases by administering artificially produced mRNA to the body and allowing the body to discover the protein encoded by the mRNA. Its pipeline includes RUNX1, the mRNA drug pipeline, non-mRNA drug pipeline, Comrex otological liquid 1.5%, NC-6100, TUG1, and others.
Calendar
2024-05-13
- Q4 2023 Earnings Release
| 1st Jan change | Capi. | |
|---|---|---|
| -4.74% | 79.06M | |
| -3.29% | 102B | |
| +1.49% | 96.29B | |
| +1.60% | 22.18B | |
| -16.07% | 21.2B | |
| -9.72% | 18.31B | |
| -38.74% | 17.38B | |
| -14.48% | 16.36B | |
| +5.59% | 13.97B | |
| +33.30% | 12.17B |
- Stock Market
- Equities
- 4571 Stock
- Funds and ETFs NANO MRNA Co.,Ltd.
